Barclays’s Spectranetics Corp SPNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-23,131
| Closed | -$888K | – | 7283 |
|
|
2017
Q2 | $888K | Buy |
23,131
+5,050
| +28% | +$146K | ﹤0.01% | 2988 |
|
|
2017
Q1 | $527K | Buy |
18,081
+1,678
| +10% | +$44.7K | ﹤0.01% | 3354 |
|
|
2016
Q4 | $402K | Sell |
16,403
-48,288
| -75% | -$1.14M | ﹤0.01% | 3579 |
|
|
2016
Q3 | $1.62M | Buy |
64,691
+64,555
| +47,467% | +$1.51M | ﹤0.01% | 2168 |
|
|
2016
Q2 | $2K | Sell |
136
-316
| -70% | -$5.57K | ﹤0.01% | 6031 |
|
|
2016
Q1 | $6K | Sell |
452
-7,948
| -95% | -$110K | ﹤0.01% | 5648 |
|
|
2015
Q4 | $126K | Buy |
8,400
+8,179
| +3,701% | +$108K | ﹤0.01% | 4256 |
|
|
2015
Q3 | $2K | Sell |
221
-36,847
| -99% | -$660K | ﹤0.01% | 6447 |
|
|
2015
Q2 | $853K | Buy |
37,068
+35,820
| +2,870% | +$1M | ﹤0.01% | 3018 |
|
|
2015
Q1 | $42K | Sell |
1,248
-2,129
| -63% | -$72.4K | ﹤0.01% | 5406 |
|
|
2014
Q4 | $115K | Buy |
3,377
+1,938
| +135% | +$60.4K | ﹤0.01% | 5086 |
|
|
2014
Q3 | $37K | Buy |
1,439
+623
| +76% | +$16.7K | ﹤0.01% | 6108 |
|
|
2014
Q2 | $19K | Sell |
816
-937
| -53% | -$21.7K | ﹤0.01% | 6544 |
|
|
2014
Q1 | $52K | Sell |
1,753
-4,867
| -74% | -$133K | ﹤0.01% | 5969 |
|
|
2013
Q4 | $167K | Sell |
6,620
-4,901
| -43% | -$105K | ﹤0.01% | 5181 |
|
|
2013
Q3 | $184K | Buy |
11,521
+2,623
| +29% | +$45.7K | ﹤0.01% | 5130 |
|
|
2013
Q2 | $166K | Buy |
+8,898
| New | +$168K | ﹤0.01% | 5356 |
|
Barclays's SPNC Position: Q3 2017 in Review
Barclays sold out of Spectranetics Corp (SPNC) in Q3 2017, closing a stake of 23,131 shares — an estimated $888K sold.
Barclays first reported a position in SPNC in Q2 2013 and held it in 17 quarters. The position peaked at $1.62M in Q3 2016. 0 funds tracked by Wall St. Rank hold SPNC as of Q3 2017.
- Barclays reported no remaining Spectranetics Corp position as of Q3 2017 after selling out during the quarter.
- Barclays sold 23,131 Spectranetics Corp shares in Q3 2017, an estimated $888K.
- Barclays first reported a position in Spectranetics Corp in Q2 2013 and held it in 17 quarters.
- Barclays's Spectranetics Corp position peaked at $1.62M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Spectranetics Corp as of Q3 2017.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.